Assessing the Influence of ICER Reports on Payer Decision Making

This advisory brief examines the influence of Institute for Clinical and Economic Review (ICER) reports on U.S. payer decision-making processes regarding healthcare interventions. It outlines the objectives of a payer survey conducted by Trinity Life Sciences, aimed at understanding how U.S. payers utilize ICER assessments in formulary decisions. The brief details the methodology of the survey, which involved 20 U.S. formulary decision-makers from various managed care organizations, and presents key findings. The findings indicate that a significant majority of U.S. payers find ICER reports helpful for formulary coverage decisions, with 65% considering them extremely or very helpful. The report also discusses the comparative value of ICER assessments against other evidence sources, such as peer-reviewed journals and internal analyses. Additionally, it highlights the growing familiarity and frequent use of ICER assessments among decision-makers, suggesting an increasing reliance on these evaluations in the healthcare landscape.